Cargando…

Efficacy of Pazopanib in the Treatment of Metastatic Malignant Giant Cell Tumor of Soft Tissue: A Case Report

Giant cell tumor of soft tissue (GCT-ST), histologically resembling the GCT of the bone, is a rare tumor. The tumor has been categorized to have low malignancy. Few reports of local recurrence or distant metastasis and the use of chemotherapeutic agents for metastatic GCT-ST exist. Herein, we report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwai, Tadashi, Oebisu, Naoto, Hoshi, Manabu, Takada, Naoki, Nakamura, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870577/ https://www.ncbi.nlm.nih.gov/pubmed/35200563 http://dx.doi.org/10.3390/curroncol29020064

Ejemplares similares

Review of the referral documents of patients with malignant soft tissue tumors
por: Hoshi, Manabu, et al.
Publicado: (2022)

Tumor-skin invasion is a reliable risk factor for poor prognosis in superficial soft tissue sarcomas
por: Iwai, Tadashi, et al.
Publicado: (2022)

An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors
por: Shimatani, Akiyoshi, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on bone and soft tissue tumor treatment: A single-institution study
por: Ban, Yoshitaka, et al.
Publicado: (2023)

Correction to: An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors
por: Shimatani, Akiyoshi, et al.
Publicado: (2021)

Finite Element Analysis Could Predict and Prevent a Pathological Femoral Shaft Fracture after En Bloc Resection of a Large Osteoid Osteoma
por: Iwai, Tadashi, et al.
Publicado: (2022)

Diagnostic value of tumor-fascia relationship in superficial soft tissue masses on magnetic resonance imaging
por: Iwai, Tadashi, et al.
Publicado: (2018)

Anti-Tumor Effect and Neurotoxicity of Ethanol Adjuvant Therapy after Surgery of a Soft Tissue Sarcoma
por: Ban, Yoshitaka, et al.
Publicado: (2023)

Role of FDG-PET/CT for monitoring soft tissue tumors
por: HOSHI, MANABU, et al.
Publicado: (2014)

Prediction of Risk Factors for Pathological Fracture After Bone Tumor Biopsy Using Finite Element Analysis
por: Iwai, Tadashi, et al.
Publicado: (2021)

High tartrate-resistant acid phosphatase (TRACP 5b) level in cystic fluid is a significant prognostic marker for postoperative recurrence in solitary bone cysts
por: Hoshi, Manabu, et al.
Publicado: (2022)

Successful pre-operative local control of skin exposure by sarcoma using combination of systemic chemotherapy and Mohs’ chemosurgery
por: Hoshi, Manabu, et al.
Publicado: (2020)

Case report demonstrating effectiveness of sorafenib in multiple lung and bone metastases of renal cell carcinoma
por: HOSHI, MANABU, et al.
Publicado: (2015)

Does Systemic Chemotherapy Influence Skeletal Growth of Young Osteosarcoma Patients as a Treatment-Related Late Adverse Effect?
por: Hoshi, Manabu, et al.
Publicado: (2022)

Osteosarcoma arising from the parapharyngeal space: A case report
por: HOSHI, MANABU, et al.
Publicado: (2014)

A Case of Dedifferentiated Liposarcoma Showing a Biphasic Pattern on 2-Deoxy-2-F(18)-Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography
por: Hoshi, Manabu, et al.
Publicado: (2013)

Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model
por: Iwai, Tadashi, et al.
Publicado: (2020)

Pazopanib in rare histologies of metastatic soft tissue sarcoma
por: Kataria, Babita, et al.
Publicado: (2021)

Successful en bloc resection for femoral head clear cell chondrosarcoma without biopsy: A case report
por: Hoshi, Manabu, et al.
Publicado: (2022)

Pazopanib: Approval for Soft-Tissue Sarcoma
por: Nguyen, Diana T., et al.
Publicado: (2013)

Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
por: Molenaar-Kuijsten, Laura, et al.
Publicado: (2021)

Pazopanib in the management of advanced soft tissue sarcomas
por: Cranmer, Lee D, et al.
Publicado: (2016)

Effect of Acid‐Suppressive Strategies on Pazopanib Efficacy in Patients With Soft‐Tissue Sarcoma
por: Pisano, Sorana G., et al.
Publicado: (2019)

Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib
por: Rajendra, Rajeev, et al.
Publicado: (2013)

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
por: Yoo, Kwai Han, et al.
Publicado: (2015)

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
por: Cesne, Axel Le, et al.
Publicado: (2019)

Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis
por: Aiba, Hisaki, et al.
Publicado: (2021)

Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders
por: Nakano, Kenji, et al.
Publicado: (2019)

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
por: Ray-Coquard, Isabelle, et al.
Publicado: (2017)

Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
por: Minot-This, Marie-Sophie, et al.
Publicado: (2022)

Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom
por: Amdahl, Jordan, et al.
Publicado: (2014)

A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma
por: Kim, Miso, et al.
Publicado: (2018)

Real-World Outcome and Prognostic Factors of Pazopanib in Advanced Soft Tissue Sarcoma
por: Alshamsan, Bader, et al.
Publicado: (2021)

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study
por: Sleijfer, S, et al.
Publicado: (2012)

Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis
por: Nakano, Kenji, et al.
Publicado: (2016)

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor
por: Ng, Dave Yong Xiang, et al.
Publicado: (2022)

Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
por: Groenland, Stefanie L., et al.
Publicado: (2018)

Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
por: Kawai, Akira, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4rff9l394jqkvs3ehmqd0o06am